Skip to search formSkip to main content

pamabrom

Known as: 2-amino-2-methyl-1-propanol-8-bromotheophyllinate, pamabrom [Chemical/Ingredient] 
A mixture containing 2-amino-2-methyl-1-propanol and 8-bromotheophylline (a methylxanthine) in a 1:1 ratio, with mild diuretic activity.
National Institutes of Health

Related topics

Related topics

12 relations
Acetaminophen 500 MG / pamabrom 25 MG / Pyrilamine Maleate 15 MG Oral TabletAcetaminophen 500 MG / pamabrom 25 MG / Pyrilamine Maleate 15 MG Oral Tablet [Premsyn PMS]Acetaminophen 500 MG / pamabrom 25 MG Oral Tablet [Backaid]Acetaminophen 500 MG / pamabrom 25 MG Oral Tablet [Painaid]
Expand

Narrower (2)

Aqua-BanSyncol

Broader (3)

Drug CombinationsPropanolaminesTheophylline

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Simultaneous Determination of Acetaminophen, Pamabrom and Pyrilamine Maleate in Pharmaceutical Formulations Using Stability Indicating HPLC Assay Method
A simple, specific and accurate stability indicating RPHPLC method was developed for the determination of acetaminophen, pamabrom… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
Naproxen, paracetamol and pamabrom versus paracetamol, pyrilamine and pamabrom in primary dysmenorrhea: a randomized, double-blind clinical trial.
INTRODUCTION Dysmenorrhea is caused by the discharge of prostaglandins into the uterine tissue; therefore, non-steroidal anti… Expand
Is this relevant?
2015
2015
HPTLC and RP-HPLC methods for simultaneous determination of Paracetamol and Pamabrom in presence of their potential impurities.
Two chromatgraphic methods were developed for determination of Paracetamol (PCM) and Pamabrom (PAM) in presence of P-aminophenol… Expand
Is this relevant?
2014
2014
Erythema Multiforme Secondary to Dimenhydrinate in a Patient With Previous Similar Reactions to Pamabrom
Objective: To report a case of erythema multiforme secondary to dimenhydrinate and pamabrom cross-sensitivity. Case Summary: A 22… Expand
  • figure 1
Is this relevant?
2014
2014
Development and Validation of RP-HPLC Method For Estimation of Pamabrom in Bulk And Marketed Formulation
Background : A rapid, sensitive and specific RP-HPLC method involving PDA detection was developed and validated for estimation of… Expand
  • figure 3
  • table 2
  • table 3
  • table 5
  • table 6
Is this relevant?
2014
2014
Development and Validation of Stability-indicating RP-HPLC Method for Estimation of Pamabrom in Tablets
The present study depicts the development of a validated RP-HPLC method for the determination of the pamabrom in presence of… Expand
  • figure 1
  • figure 2
  • table 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Primary dysmenorrhea among Mexican university students: prevalence, impact and treatment.
  • Mario I Ortiz
  • European journal of obstetrics, gynecology, and…
  • 2010
OBJECTIVE To evaluate the prevalence, impact and treatment of primary dysmenorrhea among Mexican university students. STUDY… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Prevalence and impact of primary dysmenorrhea among Mexican high school students.
OBJECTIVE To evaluate factors affecting the prevalence of dysmenorrhea in a group of Mexican students. METHOD A questionnaire… Expand
  • table 2
  • table 1
  • table 3
Is this relevant?
2007
2007
Determination of two constituents in compound acetaminophen and pamabrom tablets in human plasma by high performance liquid chromatography
AIM:To establish a rapid HPLC method for determination of acetaminophen and pamabrom in compound acetaminophen and pamabrom… Expand
Is this relevant?
Review
2004
Review
2004
Is acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea?
Primary dysmenorrhoea is the most frequent gynaecological condition, with a prevalence of 40 - 90% in women within the… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE